ATNM · Actinium Pharmaceuticals, Inc. · Documents

$1.59 +0.00 (+0.00%) At close · Nov 12

Market Cap

$49.99M

31.44M

Volume · Nov 12 348.12K Avg daily vol (3M) 190.03K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2021

Nov 12

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $233K Net loss $6.42M

Nov 9

Current report 8-K

Director or officer change, or executive pay, Shareholder vote results

Nov 5

Proxy statement DEFA14A

Proxy statement

Oct 18

Proxy statement DEF 14A Meeting Nov 9, 2021

Proxy statement

Sep 23

Current report 8-K Events of Sep 22

Director or officer change, or executive pay, Regulation FD disclosure

Jul 30

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $266K Net loss $5.02M

May 14

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $622K Net loss $5.32M

Mar 31

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Net loss $22.22M

2020

Nov 20

Current report 8-K Events of Nov 18

Director or officer change, or executive pay, Shareholder vote results

Oct 28

Current report 8-K

Regulation FD disclosure

Oct 28

Proxy statement DEFA14A

Proxy statement

Oct 23

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Net loss $5.54M

Oct 7

Proxy statement DEF 14A Meeting Nov 18, 2020

Proxy statement

Oct 7

Proxy statement DEFA14A

Proxy statement

Aug 14

Current report 8-K Events of Aug 10

Charter or bylaw amendment, or fiscal year change, Other events

Aug 14

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Net loss $4.63M

Aug 7

Registration statement S-3

Registration statement

Aug 5

Current report 8-K

Other events

Jul 24

Current report 8-K Events of Jul 22

Other events

Jul 13

Annual report 10-K/A Ended Dec 31

Annual report for the period ended Dec 31, 2019

Jun 29

Quarterly report 10-Q FY2020 Q1, ended Mar 31

Quarterly report for FY2020 Q1

Net loss $5.67M

Jun 19

Current report 8-K

Other events

Jun 18

Current report 8-K Events of Jun 16

Entered into a material agreement, Other events

Jun 16

Current report 8-K

Charter or bylaw amendment, or fiscal year change

Jun 16

Annual report 10-K/A Ended Dec 31

Annual report for the period ended Dec 31, 2019

Jun 16

Current report 8-K

Other events

May 15

Current report 8-K

Other events

May 8

Annual report 10-K FY2019, ended Dec 31

Annual report for FY2019

Net loss $21.9M

May 5

Current report 8-K Events of Apr 29

Delisting notice or listing transfer

May 5

Current report 8-K

Charter or bylaw amendment, or fiscal year change

Apr 24

Current report 8-K Events of Apr 21

Entered into a material agreement

Mar 27

Current report 8-K Events of Mar 20

Other events

Showing 51–82 of 82 documents

Key facts CIK 1388320 CUSIP 00507W206 13F (30d) 33 filings 23 filers Visit website Investor relations